Chronic Obstructive Pulmonary Disease

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

What is Chronic Obstructive Pulmonary Disease?

Chronic obstructive pulmonary disease (COPD) is an assortment of lung disorders that includes...

Chronic Obstructive Pulmonary Disease Causes

Chronic Obstructive Pulmonary Disease Process

Chronic Obstructive Pulmonary Disease Management

History of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Symptoms

Chronic Obstructive Pulmonary Disease Diagnosis

Foods That Can Irritate COPD

COPD Risk Factors

Types of Inhalers in Pulmonary Disease

Phenotyping of Chronic Obstructive Pulmonary Disease (COPD)

What are the Differences between Asthma and COPD?

See more featured articles »

Contemporary Topics in Pulmonary Medicine

Pulmonary Function Tests in COPD Progression Monitoring

Latest Chronic Obstructive Pulmonary Disease News and Research

Air pollution and cold temperatures drive bronchiectasis mortality in vulnerable populations

Researchers investigate how short-term exposure to ambient air pollution and temperature affects bronchiectasis mortality rates in China.

26 Nov 2024

World’s first fully robotic double lung transplant performed at NYU Langone Health

A surgical team at NYU Langone Health has performed the first fully robotic double lung transplant in the world.

21 Nov 2024

AI used to predict COPD flare ups from urine samples

Researchers have used artificial intelligence (AI) to analyse patient urine samples and predict when symptoms of chronic obstructive pulmonary disease (COPD) will flare up according to a study published today (Wednesday) in ERJ Open Research.

20 Nov 2024

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering potential new treatments for asthma.

19 Nov 2024

Study focuses on COPD progression in younger populations

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses, according to a new article.

15 Nov 2024

High blood pressure, atrial fibrillation and smoking linked to severe stroke risk

People with conditions or habits such as high blood pressure, an irregular heartbeat called atrial fibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these risk factors, according to a study published in the November 13, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

13 Nov 2024

Study reveals high prevalence of unrecognized cognitive impairment in vulnerable older adults

One of the first studies to investigate the prevalence of unrecognized cognitive impairment among patients seen at Federally Qualified Health Centers, has found that it is ubiquitous, especially among minoritized older adults.

8 Nov 2024

New approach to COPD focuses on socioeconomic factors and comorbidities

Health care providers treating people with COPD also need to focus on the person's socioeconomic factors, along with considering their additional health conditions or comorbidities, according to a new article.

7 Nov 2024

New overtime limits for physicians aimed at improving sleep and mental health

Physicians are a vital component of the healthcare landscape and along with other medical professionals, they ensure timely diagnosis, treatment, and management of complex illnesses.

4 Nov 2024

Abnormal BMI in children linked to impaired lung function

An abnormal BMI in children - be it high or low - can now be associated with impaired lung function, but if their BMI is normalized before they reach adulthood, the impairment can be offset, researchers from Karolinska Institutet report.

28 Oct 2024

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Antibiotic exposure shows potential protective effects against Parkinson's, while antifungal use is linked to increased risk, indicating microbiome involvement.

28 Oct 2024

Investigating the relationship between COPD and liver disease in alpha-1 antitrypsin deficiency

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1 antitrypsin (AAT) within hepatocytes, which limits its access to the circulation and exposes the lungs to protease-mediated tissue damage.

26 Oct 2024

Mountain town confronts an unexpected public health catastrophe

Before Hurricane Helene, had you stopped by one of the many breweries, art galleries, or award-winning restaurants in Asheville, North Carolina, and spoken with anyone who lives in these parts — including me — most would have told you they felt pretty safe from climate disasters.

18 Oct 2024

$Severe mental illness linked to higher risk of fragility fractures in older adults$

Severe mental illness linked to higher risk of fragility fractures in older adults

People over the age of 50 who have severe mental illness are more likely than the general population to experience fragility fractures but may be less likely to get a diagnosis for osteoporosis, finds a new study led by UCL researchers.

15 Oct 2024

New study reveals unique metabolic function of lung-resident NK immune cells

Trinity College Dublin researchers, based at St James's Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial 'natural killer' (NK) immune cell resident in the lungs.

12 Oct 2024

COVID-19 increases chronic fatigue risk

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as older adults, Asians, and non-hospitalized patients, at higher risk.

7 Oct 2024

New insights into the link between respiratory infections and chronic lung diseases

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green).

3 Oct 2024

Accelerating tobacco decline could boost global life expectancy

Accelerating the decline in tobacco smoking globally, by decreasing smoking prevalence from current levels to 5% everywhere, could increase life expectancy and prevent millions of premature deaths by 2050, according to a study from the Global Burden of Disease, Injuries and Risk Factors (GBD) Tobacco Forecasting Collaborators published in The Lancet Public Health journal.

3 Oct 2024

Study uncovers biological drivers of plasma proteins, offering new insights for disease biomarkers and drug discovery

Researchers mapped the biological influences on 4,775 plasma proteins, revealing the interplay of modifiable and non-modifiable factors, with key implications for disease biomarkers and drug targets.

30 Sep 2024

Research reveals key role of mucin modification in muco-obstructive diseases

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of the first lines of defense and aids in removal these microbes.

24 Sep 2024